Dr. Reddy’s Laboratories Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Dr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4462
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Dr. Reddy’s Laboratories Limited – Strategy, SWOT and Corporate Finance Report
Summary

Dr. Reddy’s Laboratories Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Dr. Reddy’s Laboratories (DRL or ‘the company’) is an integrated pharmaceutical company that offers generics, over the counter, active pharmaceutical ingredients (APIs), and proprietary products. The generics products are ready for consumption by the customer product and specified for the areas of gastrointestinal, cardiovascular, pain management, oncology, anti-infectives, pediatrics and central nervous system. It also offers pharmaceutical services and active ingredients product that consists of active pharmaceutical products or bulk drugs. DRL is engaged in the discovery of new chemical entities for the areas of metabolic disorders, pain and inflammation. The company operates in India, North America, Europe, Russia and other countries of the former Soviet Union. DRL is headquartered in Hyderabad,Telengana, India.

Scope

- Detailed information on Dr. Reddy’s Laboratories Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Dr. Reddy’s Laboratories Limited in the form of a SWOT analysis
- An in-depth view of the business model of Dr. Reddy’s Laboratories Limited including a breakdown and examination of key business segments
- Intelligence on Dr. Reddy’s Laboratories Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Dr. Reddy’s Laboratories Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Dr. Reddy’s Laboratories Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Dr. Reddy’s Laboratories Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Dr. Reddy’s Laboratories Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Dr. Reddy’s Laboratories Limited: Company Overview 9
Dr. Reddy’s Laboratories Limited: Overview and Key Facts 9
Dr. Reddy’s Laboratories Limited: Overview 9
Dr. Reddy’s Laboratories Limited: Key Facts 9
Dr. Reddy’s Laboratories Limited: Key Employees 11
Dr. Reddy’s Laboratories Limited: Key Employee Biographies 13
Dr. Reddy’s Laboratories Limited: Major Products and Services 20
Dr. Reddy’s Laboratories Limited: Company History 21
Dr. Reddy’s Laboratories Limited: Management Statement 27
Dr. Reddy’s Laboratories Limited: Locations and Subsidiaries 29
Dr. Reddy’s Laboratories Limited: Key Competitors 31
Dr. Reddy’s Laboratories Limited: Company Analysis 32
Dr. Reddy’s Laboratories Limited: Business Description 32
Dr. Reddy’s Laboratories Limited: SWOT Analysis 33
Dr. Reddy’s Laboratories Limited: SWOT Overview 33
Dr. Reddy’s Laboratories Limited: Strengths 33
Dr. Reddy’s Laboratories Limited: Weaknesses 34
Dr. Reddy’s Laboratories Limited: Opportunities 35
Dr. Reddy’s Laboratories Limited: Threats 37
Dr. Reddy’s Laboratories Limited: Corporate Financial Deals Activity 39
Dr. Reddy’s Laboratories Limited: Financial Deals Overview 39
Dr. Reddy’s Laboratories Limited: Targets and Partners 41
Dr. Reddy’s Laboratories Limited: Top Deals 2014 – 2018YTD* 43
Dr. Reddy’s Laboratories Limited: Mergers and Acquisitions 44
Dr. Reddy’s Laboratories Limited: Partnership 45
Dr. Reddy’s Laboratories Limited: Divestments 46
Dr. Reddy’s Laboratories Limited: Recent Developments 47
Dr. Reddy’s Laboratories Limited: News and Events Summary 47
Dr. Reddy’s Laboratories Limited: Business Expansion 50
Dr. Reddy’s Laboratories Limited: Corporate Governance 50
Dr. Reddy’s Laboratories Limited: Financial Performance 51
Dr. Reddy’s Laboratories Limited: Regulatory and Legal Events 51
Appendix 54
Contact Us 54
Methodology 54
About MarketLine 55

List of Tables
Table 1: Dr. Reddy's Laboratories Limited: Key Facts
Table 2: Dr. Reddy's Laboratories Limited: Key Employees
Table 3: Dr. Reddy's Laboratories Limited: Locations and Subsidiaries
Table 4: Dr. Reddy's Laboratories Limited: Key Competitors
Table 5: Dr. Reddy's Laboratories Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Dr. Reddy's Laboratories Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Dr. Reddy's Laboratories Limited: M&A Average Deal Size - Value (US$m)
Table 8: Dr. Reddy's Laboratories Limited: Targets and Partners
Table 9: Dr. Reddy's Laboratories Limited: Top Deals 2014 - 2018YTD*
Table 10: Dr. Reddy's Laboratories Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Dr. Reddy's Laboratories Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 12: Dr. Reddy's Laboratories Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: Dr. Reddy's Laboratories Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 14: Dr. Reddy's Laboratories Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 15: Dr. Reddy's Laboratories Limited: News and Events Summary
Table 16: Dr. Reddy's Laboratories Limited: Business Expansion
Table 17: Dr. Reddy's Laboratories Limited: Corporate Governance
Table 18: Dr. Reddy's Laboratories Limited: Financial Performance
Table 19: Dr. Reddy's Laboratories Limited: Regulatory and Legal Events

List of Figures
Figure 1: Dr. Reddy's Laboratories Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Dr. Reddy's Laboratories Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Dr. Reddy's Laboratories Limited: M&A Average Deal Size - Value (US$m)
Figure 4: Dr. Reddy's Laboratories Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Dr. Reddy's Laboratories Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Dr. Reddy's Laboratories Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Dr. Reddy's Laboratories Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 8: Dr. Reddy's Laboratories Limited: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Dr. Reddy’s Laboratories Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Morphogenesis Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Morphogenesis Inc (Morphogenesis) is a developer of novel cell and gene therapies to detect, monitor and control cancer. The company manufactures products based on distinct and synergistic technology platforms. It uses technologies such as immunefx cancer immunotherapies, the polymer antibod …
  • The Ambassador Hotel Co. Ltd.:企業の戦略・SWOT・財務情報
    The Ambassador Hotel Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Ambassador Hotel Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • EnWave Corp (ENW)-製薬・医療分野:企業M&A・提携分析
    Summary EnWave Corp (EnWave) is an advanced technology company that provides industrial-scale dehydration technology for commercial applications in the pharmaceutical and food industries. It designs, constructs, markets and sells microwavevacuum biomaterial and food dehydration machines that use pro …
  • Esselte Corporation:企業の戦略・SWOT・財務分析
    Esselte Corporation - Strategy, SWOT and Corporate Finance Report Summary Esselte Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Linedata Services SA (LIN):企業の財務・戦略的SWOT分析
    Linedata Services SA (LIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Noerr LLP:企業の戦略的SWOT分析
    Noerr LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Karoon Gas Australia Ltd (KAR):石油・ガス:M&Aディール及び事業提携情報
    Summary Karoon Gas Australia Ltd (Karoon) is a major independent upstream oil and gas company, which explores for oil and gas and develops assets. It also operates projects in Brazil and Peru. Karoon has significant drilling opportunities in proven and prospective petroleum systems. The company focu …
  • Reliance Steel & Aluminum Co
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • QuadGraphics, Inc. (QUAD):企業の財務・戦略的SWOT分析
    QuadGraphics, Inc. (QUAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sumitomo Mitsui Banking Corp:企業のM&A・事業提携・投資動向
    Sumitomo Mitsui Banking Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sumitomo Mitsui Banking Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報
    Summary Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and bi …
  • Intellicheck, Inc. (IDN):企業の財務・戦略的SWOT分析
    Intellicheck, Inc. (IDN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Perrigo Company Plc (PRGO):医療機器:M&Aディール及び事業提携情報
    Summary Perrigo Company plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic and prescription pharmaceuticals, specialty pharmaceutical company, nutritional products, active pharmaceutic …
  • S. Kumars Nationwide Limited:戦略・SWOT・企業財務分析
    S. Kumars Nationwide Limited - Strategy, SWOT and Corporate Finance Report Summary S. Kumars Nationwide Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cadence Design Systems, Inc.:企業のM&A・事業提携・投資動向
    Cadence Design Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cadence Design Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • First Republic Bank:企業の戦略・SWOT・財務情報
    First Republic Bank - Strategy, SWOT and Corporate Finance Report Summary First Republic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Central Garden & Pet Company:企業の戦略・SWOT・財務情報
    Central Garden & Pet Company - Strategy, SWOT and Corporate Finance Report Summary Central Garden & Pet Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Mycenax Biotech Inc (4726):企業の財務・戦略的SWOT分析
    Summary Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, …
  • Silverleaf Resorts, Inc.:企業の戦略・SWOT・財務情報
    Silverleaf Resorts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silverleaf Resorts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆